Study of the Efficacy and Safety of FolateScan (Technetium TC99m EC20) in Patients With Rheumatoid Arthritis and Other Inflammatory Diseases

Trial Profile

Study of the Efficacy and Safety of FolateScan (Technetium TC99m EC20) in Patients With Rheumatoid Arthritis and Other Inflammatory Diseases

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Nov 2014

At a glance

  • Drugs Technetium Tc99m etarfolatide (Primary)
  • Indications Crohn's disease; Multiple sclerosis; Osteoarthritis; Rheumatoid arthritis; Systemic lupus erythematosus
  • Focus Diagnostic use
  • Most Recent Events

    • 21 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top